Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal …
Over the last 12 months, insiders at Myomo, Inc. have bought $350,000 and sold $300,405 worth of Myomo, Inc. stock.
On average, over the past 5 years, insiders at Myomo, Inc. have bought $206,754 and sold $134,625 worth of stock each year.
Highest buying activity among insiders over the last 12 months: KIRK THOMAS F (director) — $350,000.
The last purchase of 50,000 shares for transaction amount of $175,000 was made by KIRK THOMAS F (director) on 2024‑05‑29.
2024-09-05 | Sale | Chief Medical Officer | 6,700 0.0221% | $3.76 | $25,183 | +4.11% | ||
2024-09-03 | Sale | Chief Medical Officer | 2,029 0.0069% | $4.01 | $8,140 | +0.77% | ||
2024-05-29 | director | 50,000 0.174% | $3.50 | $175,000 | +12.10% | |||
2024-05-15 | Sale | Chief Medical Officer | 35,426 0.1201% | $3.69 | $130,839 | +2.65% | ||
2024-03-14 | director | 50,000 0.1683% | $3.50 | $175,000 | +9.88% | |||
2023-12-08 | Sale | director | 14,997 0.0571% | $4.08 | $61,188 | -6.44% | ||
2023-12-01 | Sale | Chief Medical Officer | 8,333 0.0296% | $3.12 | $26,016 | +13.56% | ||
2023-11-28 | Sale | director | 14,997 0.0574% | $3.27 | $49,040 | +17.76% | ||
2023-11-20 | director | 50,000 0.1929% | $3.10 | $155,000 | +24.22% | |||
2023-09-08 | director | 15,000 0.0565% | $1.06 | $15,867 | +224.53% | |||
2023-08-30 | Chief Executive Officer | 48,400 0.2365% | $0.74 | $36,039 | +360.81% | |||
2023-08-29 | Chief Executive Officer | 37,000 0.1804% | $0.78 | $28,797 | +332.74% | |||
2023-08-29 | Chief Financial Officer | 41,666 0.1566% | $0.60 | $25,000 | +332.74% | |||
2023-08-29 | Chief Medical Officer | 8,333 0.0313% | $0.60 | $5,000 | +332.74% | |||
2023-08-28 | Chief Executive Officer | 42,500 0.1883% | $0.75 | $31,794 | +325.63% | |||
2023-01-17 | Chief Executive Officer | 307,692 0.9391% | $0.33 | $100,000 | +66.02% | |||
2023-01-17 | Chief Financial Officer | 76,923 0.2348% | $0.33 | $25,000 | +66.02% | |||
2023-01-17 | Chief Commerical Officer | 15,384 0.047% | $0.33 | $5,000 | +66.02% | |||
2022-11-22 | Chief Financial Officer | 9,000 0.1177% | $0.55 | $4,960 | +12.54% | |||
2022-08-05 | Sale | 7,141 0.1017% | $1.71 | $12,218 | -60.94% |
KIRK THOMAS F | director | 236499 0.7819% | $5.13 | 5 | 0 | <0.0001% |
Kovelman Harry | Chief Medical Officer | 123556 0.4085% | $5.13 | 1 | 4 | |
GUDONIS PAUL R | Chief Executive Officer | 878245 2.9037% | $5.13 | 9 | 0 | <0.0001% |
HENRY DAVID A | Chief Financial Officer | 352193 1.1644% | $5.13 | 5 | 0 | <0.0001% |
SANGHI STEVE | director | 298513 0.987% | $5.13 | 1 | 0 |
Aigh Capital Management Llc | $9.16M | 9.73 | 2.8M | +5.03% | +$439,167.55 | 5.24 | |
Herr Investment Group Llc | $5.38M | 5.71 | 1.65M | +67.86% | +$2.18M | 1.74 | |
The Vanguard Group | $3.81M | 4.05 | 1.17M | -4.22% | -$168,198.98 | <0.0001 | |
ESSEX INVESTMENT MANAGEMENT CO LLC | $1.97M | 2.09 | 602,744 | +537.86% | +$1.66M | 0.4 | |
Renaissance Technologies | $921,000.00 | 0.98 | 281,700 | +45.51% | +$288,037.27 | <0.01 |